HK/China Healthcare Analyst (ex-Fosun Pharma)

Xinyao (Criss) Wang

Over 15 years' experience in both finance and healthcare, covering clinic operations, investment and equity research in both China and overseas.

Greatview Aseptic Packaging (468.HK) - Newjf Already Has an Upper Hand

Greatview Aseptic Packaging (468.HK) - The Story Behind The “Hostile Offer”

Greatview Aseptic Packaging (468.HK) Update - Some New Information Worth the Attention

CPMC Holdings (906.HK) Update - These Are the Reasons Why We Find This Deal "Tricky"

Equity Bottom-Up

Greatview Aseptic Packaging / Equity Bottom-Up

<ul>
<li>All Pre-Conditions of Newjf’s Offer have been satisfied. Based on Offer Document, the latest date for posting of the Response Document is Jan.7, 2025. First Closing Date is Jan.21, 2025.</li>
<li>Newjf will make every effort to complete the acquisition and regain the control of international business so as to protect shareholders’ interests.So, the logic behind the deal is very solid.</li>
<li>Mengniu's attitude could be positive. A higher management offer seems more out of reach because the management lacks sincerity. We advise investors not to walk away from Newjf’s Offer easily.</li>
</ul>


All Pre-Conditions of Newjf’s Offer have been satisfied. Based on Offer Document, the latest date for posting of the Response Document is Jan.7, 2025. First Closing Date is Jan.21, 2025.
Newjf will make every effort to complete the acquisition and regain the control of international business so as to protect shareholders’ interests.So, the logic behind the deal is very solid.
Mengniu's attitude could be positive. A higher management offer seems more out of reach because the management lacks sincerity. We advise investors not to walk away from Newjf’s Offer easily.


Shandong Xinjufeng Technology Packaging (301296 CH)

Greatview Aseptic Packaging (468.HK) Update - Newjf’s Offer Should Be Prioritized